Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways-Reference-Cited by-同舟云学术

Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways

Published:2024-05 Issue: Volume:51 Page:100991
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Ni Lianli,Zhu Xinping,Zhao Qi,Shen Yiwei,Tao Lu,Zhang Ji,Lin Han,Zhuge Weishan,Cho Young-Chang,Cui Ri,Zhu Wangyu

Funder

Zhejiang Provincial Health Commission

National Natural Science Foundation of China

Zhejiang Province Natural Science Foundation

Publisher

Elsevier BV

Reference69 articles.

1. Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells;Testa;Cancers (Basel),2018

2. Cancer statistics, 2022;Siegel;Ca-A Cancer J. Clin.,2022

3. Non-small-cell lung cancer;Gridelli;Nat. Rev. Dis. Primers,2015

4. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC;Ramalingam;N. Engl. J. Med.,2020

5. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019;Newman;J. Nat. Prod.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune escape between endoplasmic reticulum stress-related cancer cells and exhausted CD8+T cells leads to neoadjuvant chemotherapy resistance in ovarian cancer;Biochemical and Biophysical Research Communications;2024-11

2. Expression of LASS2 Can be Regulated by Dihydroartemisinin to Regulate Cisplatin Chemosensitivity in Bladder Cancer Cells;Current Pharmaceutical Biotechnology;2024-05-16